ATE136465T1 - Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis - Google Patents

Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis

Info

Publication number: ATE136465T1
Authority: AT; Austria
Prior art keywords: prostatitis; treatment; gibberellins; production; medicinal product
Prior art date: 1989-12-12

Application number

AT91900992T

Other languages

English (en)

Inventor

Per Oden

Original Assignee

Per Oden

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-12

Filing date

1990-12-10

Publication date

1996-04-15

1990-12-10 Application filed by Per Oden filed Critical Per Oden

1996-04-15 Application granted granted Critical

1996-04-15 Publication of ATE136465T1 publication Critical patent/ATE136465T1/de

Links

229930191978 Gibberellin Natural products 0.000 title abstract 2
239000003448 gibberellin Substances 0.000 title abstract 2
IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 title abstract 2
201000007094 prostatitis Diseases 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
201000004681 Psoriasis Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P27/00—Preparation of compounds containing a gibbane ring system, e.g. gibberellin
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Hematology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Dermatology (AREA)
General Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Reproductive Health (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

AT91900992T 1989-12-12 1990-12-10 Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis ATE136465T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK627289A DK627289D0 (da)	1989-12-12	1989-12-12	Anvendelse af bicyclononanderivater

Publications (1)

Publication Number	Publication Date
ATE136465T1 true ATE136465T1 (de)	1996-04-15

Family

ID=8148421

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91900992T ATE136465T1 (de)	1989-12-12	1990-12-10	Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis

Country Status (11)

Country	Link
EP (1)	EP0504254B1 (de)
JP (1)	JPH05502227A (de)
KR (1)	KR920703088A (de)
AT (1)	ATE136465T1 (de)
AU (1)	AU648529B2 (de)
CA (1)	CA2069002A1 (de)
DE (1)	DE69026511T2 (de)
DK (1)	DK627289D0 (de)
ES (1)	ES2087279T3 (de)
NO (1)	NO922136D0 (de)
WO (1)	WO1991008751A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT674521E (pt) *	1992-12-18	2001-10-31	Merck & Co Inc	Metedo para o tratamento da prostatite cronica com 17beta-n-carbamoil monossubstituido-4-aza-5alfa-androst-1-en-3-onas
SE9301606D0 (sv) *	1993-05-07	1993-05-07	Per-Christer Oden	Composition for the treatment of impaired hair growth
FR2707646A1 (fr) *	1993-07-15	1995-01-20	Univ Toulouse	Procédé d'extraction et de purification de saponines hémolytiques.
JP4234198B2 (ja) *	1995-01-06	2009-03-04	オーストラリアン・バイオメディカル・カンパニー・プロプライアタリー・リミテッド	獣医学および医学用途用化合物
US7098189B2 (en)	2002-12-16	2006-08-29	Kimberly-Clark Worldwide, Inc.	Wound and skin care compositions
WO2004058151A2 (en) *	2002-12-16	2004-07-15	Kimberly-Clark Worldwide, Inc.	Wound and skin care compositions
US7485666B2 (en)	2004-06-17	2009-02-03	Kimberly-Clark Worldwide, Inc.	Vaginal health products
JP5615484B2 (ja) *	2008-01-15	2014-10-29	株式会社エス・ネット	５α‐リダクターゼ阻害剤
CN102526254B (zh) *	2012-02-08	2013-12-18	李宁	一种治疗男性前列腺炎的中药组合物
JP6761705B2 (ja) *	2016-02-01	2020-09-30	株式会社日本健康食品研究所	５α−リダクターゼ阻害剤及び泌尿器系疾患治療・予防用組成物ならびにこれらの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4424232A (en) *	1982-05-19	1984-01-03	Parkinson Richard W	Treatment of herpes simplex

1989
- 1989-12-12 DK DK627289A patent/DK627289D0/da not_active Application Discontinuation
1990
- 1990-12-10 CA CA002069002A patent/CA2069002A1/en not_active Abandoned
- 1990-12-10 ES ES91900992T patent/ES2087279T3/es not_active Expired - Lifetime
- 1990-12-10 KR KR1019920701387A patent/KR920703088A/ko not_active Ceased
- 1990-12-10 WO PCT/SE1990/000815 patent/WO1991008751A1/en not_active Ceased
- 1990-12-10 DE DE69026511T patent/DE69026511T2/de not_active Expired - Fee Related
- 1990-12-10 AU AU69138/91A patent/AU648529B2/en not_active Ceased
- 1990-12-10 AT AT91900992T patent/ATE136465T1/de not_active IP Right Cessation
- 1990-12-10 EP EP91900992A patent/EP0504254B1/de not_active Expired - Lifetime
- 1990-12-10 JP JP3501393A patent/JPH05502227A/ja active Pending
1992
- 1992-05-29 NO NO922136A patent/NO922136D0/no unknown

Also Published As

Publication number	Publication date
NO922136L (no)	1992-05-29
CA2069002A1 (en)	1991-06-13
JPH05502227A (ja)	1993-04-22
KR920703088A (ko)	1992-12-17
WO1991008751A1 (en)	1991-06-27
ES2087279T3 (es)	1996-07-16
DK627289D0 (da)	1989-12-12
AU648529B2 (en)	1994-04-28
EP0504254A1 (de)	1992-09-23
DE69026511T2 (de)	1996-11-21
EP0504254B1 (de)	1996-04-10
AU6913891A (en)	1991-07-18
NO922136D0 (no)	1992-05-29
DE69026511D1 (de)	1996-05-15

Similar Documents

Publication	Publication Date	Title
DE3752045D1 (de)	1997-05-07	Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten
DE3684190D1 (de)	1992-04-16	Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE59000270D1 (de)	1992-10-01	Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
DE69003652D1 (de)	1993-11-04	Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE59309043D1 (de)	1998-11-12	Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und diese enthaltenden pharmazeutischen Präparaten
ATE330593T1 (de)	2006-07-15	Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
DE68923819D1 (de)	1995-09-21	Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE69011951D1 (de)	1994-10-06	Verfahren zur Behandlung und Herstellung von Material.
ATE55695T1 (de)	1990-09-15	Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
DE68924714D1 (de)	1995-12-07	Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE3770465D1 (de)	1991-07-04	Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.
ATE136465T1 (de)	1996-04-15	Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE3850154D1 (de)	1994-07-21	Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE3582594D1 (de)	1991-05-23	Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
DE58903917D1 (de)	1993-05-06	Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels sowie daraus hergestelltes arzneimittel und verfahren zu seiner herstellung.
ATE89728T1 (de)	1993-06-15	Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE192929T1 (de)	2000-06-15	Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE59304087D1 (de)	1996-11-14	Placentaextrakt und Verfahren zu seiner Herstellung
DE3686097D1 (de)	1992-08-27	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE68916777D1 (de)	1994-08-18	Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
DE69300037D1 (de)	1995-02-09	Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69424415D1 (de)	2000-06-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE69009989D1 (de)	1994-07-21	Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.

Legal Events

Date	Code	Title	Description
1996-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties